Curacle Co Ltd
KOSDAQ:365270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Curacle Co Ltd
KOSDAQ:365270
|
KR |
|
GL Events SA
PAR:GLO
|
FR |
|
O
|
Origin Energy Ltd
F:ORL
|
AU |
|
M
|
MITCON Consultancy & Engineering Services Ltd
NSE:MITCON
|
IN |
|
H
|
Health In Tech Inc
NASDAQ:HIT
|
US |
Intrinsic Value
Is Curacle Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Curacle Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Curacle Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Curacle Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Curacle Does
Curacle Co Ltd is a South Korean biotechnology company that develops new medicines, mainly drug candidates for diseases tied to blood vessels, inflammation, and fibrosis. Its work is centered on early- and mid-stage research, where it designs and tests compounds that could become prescription drugs. Unlike a drugstore or generic maker, Curacle is focused on creating new treatment candidates rather than selling finished medicines directly.
- Headquarters
- Korea KR
- Employees
- 39
- IPO date
- Jul 22, 2021
Earnings Waterfall
Curacle Co Ltd
The intrinsic value for Curacle Co Ltd (365270) under the Base Case is hidden KRW.
Compared with the current market price of 8 670 KRW, the stock appears hidden.